GB0618613D0 - Benzopyranone derivatives as antiviral agents - Google Patents
Benzopyranone derivatives as antiviral agentsInfo
- Publication number
- GB0618613D0 GB0618613D0 GBGB0618613.4A GB0618613A GB0618613D0 GB 0618613 D0 GB0618613 D0 GB 0618613D0 GB 0618613 A GB0618613 A GB 0618613A GB 0618613 D0 GB0618613 D0 GB 0618613D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antiviral agents
- benzopyranone derivatives
- benzopyranone
- derivatives
- antiviral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical class C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0519797.5A GB0519797D0 (en) | 2005-09-29 | 2005-09-29 | Therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0618613D0 true GB0618613D0 (en) | 2006-11-01 |
GB2430621A GB2430621A (en) | 2007-04-04 |
Family
ID=35394932
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0519797.5A Ceased GB0519797D0 (en) | 2005-09-29 | 2005-09-29 | Therapeutic agents |
GB0618613A Withdrawn GB2430621A (en) | 2005-09-29 | 2006-09-22 | Benzopyranone derivatives as antiviral agents |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0519797.5A Ceased GB0519797D0 (en) | 2005-09-29 | 2005-09-29 | Therapeutic agents |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB0519797D0 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879797B2 (en) | 2005-05-02 | 2011-02-01 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
US7470664B2 (en) | 2005-07-20 | 2008-12-30 | Merck & Co., Inc. | HCV NS3 protease inhibitors |
WO2007016441A1 (en) | 2005-08-01 | 2007-02-08 | Merck & Co., Inc. | Macrocyclic peptides as hcv ns3 protease inhibitors |
GB0609492D0 (en) | 2006-05-15 | 2006-06-21 | Angeletti P Ist Richerche Bio | Therapeutic agents |
GB0612423D0 (en) | 2006-06-23 | 2006-08-02 | Angeletti P Ist Richerche Bio | Therapeutic agents |
EP2076278B1 (en) | 2006-10-24 | 2015-05-06 | Merck Sharp & Dohme Corp. | Macrocyclic HCV NS3 protease inhibitors |
EP2079479B1 (en) | 2006-10-24 | 2014-11-26 | Merck Sharp & Dohme Corp. | Hcv ns3 protease inhibitors |
EP2079480B1 (en) | 2006-10-24 | 2013-06-05 | Merck Sharp & Dohme Corp. | Hcv ns3 protease inhibitors |
CN101568346B (en) | 2006-10-27 | 2015-11-25 | 默沙东公司 | HCV NS3 protease inhibitor |
MX2009004556A (en) | 2006-10-27 | 2009-07-10 | Merck & Co Inc | Hcv ns3 protease inhibitors. |
CN103224506A (en) | 2006-12-20 | 2013-07-31 | P.安杰莱蒂分子生物学研究所 | Antiviral indoles |
GB0625349D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
GB0625345D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
AU2008277440A1 (en) | 2007-07-17 | 2009-01-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Macrocyclic indole derivatives for the treatment of hepatitis C infections |
US8927569B2 (en) | 2007-07-19 | 2015-01-06 | Merck Sharp & Dohme Corp. | Macrocyclic compounds as antiviral agents |
US8461107B2 (en) | 2008-04-28 | 2013-06-11 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
SI2310095T1 (en) | 2008-07-22 | 2013-01-31 | Merck Sharp & Dohme Corp. | Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
EP2459582B1 (en) | 2009-07-30 | 2015-05-27 | Merck Sharp & Dohme Corp. | Hepatitis c virus ns3 protease inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003504327A (en) * | 1999-07-08 | 2003-02-04 | プレンダーガスト、パトリック、ティ. | Use of flavones, coumarins and related compounds for the treatment of infectious diseases |
JP4647757B2 (en) * | 1999-08-18 | 2011-03-09 | 富山化学工業株式会社 | Chromone derivatives or salts thereof and antifungal agents containing them |
CN100534426C (en) * | 2004-05-28 | 2009-09-02 | 养生堂有限公司 | Novel use of chromene compound |
-
2005
- 2005-09-29 GB GBGB0519797.5A patent/GB0519797D0/en not_active Ceased
-
2006
- 2006-09-22 GB GB0618613A patent/GB2430621A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB0519797D0 (en) | 2005-11-09 |
GB2430621A (en) | 2007-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0618613D0 (en) | Benzopyranone derivatives as antiviral agents | |
HUS2000022I1 (en) | Tiglien-3-one derivatives | |
HK1129305A1 (en) | Substituted 4-amino-pyrrolo-triazine derivatives 4-- | |
EP1878727A4 (en) | 2-aminoquinazoline derivatives | |
IL192092A0 (en) | Aryl-isoxazolo-4-yl-oxadiazole derivatives | |
ZA200707358B (en) | 1-benzylindole-2-carboxamide derivatives | |
IL191907A0 (en) | Azepinoindole derivatives as pharmaceutical agents | |
AP2008004486A0 (en) | Pyrimidine derivatives | |
IL184844A0 (en) | ??-cyclodextrin derivatives as antibacterial agents | |
HK1123219A1 (en) | Diarylether derivatives as antitumor agents | |
GB0525080D0 (en) | Pyrimidine derivatives | |
HK1115321A1 (en) | Camptothecin derivatives as chemoradiosensitizing agents | |
PL1954674T3 (en) | New n-phenethylcarboxamide derivatives | |
IL184006A0 (en) | 1h-imidiazole derivatives as cannabinoid | |
ZA200802421B (en) | 1-Acyldihydropyrazol derivatives | |
ZA200802088B (en) | 4-Phenyl-6-substitued-pyrimidine-2-carbonitrile derivatives | |
ZA200804257B (en) | Azaindole-2-carboxamide derivatives | |
GB0525081D0 (en) | Pyrimidine derivatives | |
IL184841A0 (en) | Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives | |
IL192235A0 (en) | Aryl-isoxazol-4-yl-imidazole derivatives | |
EP1893629A4 (en) | Antiviral compounds | |
IL193449A0 (en) | Substituted arylsulfonamides as antiviral agents | |
IL191138A0 (en) | Pyrazoloisoquinoline derivatives | |
SG133468A1 (en) | Benzopyranone derivatives and their use as anti-viral agents | |
GB0511410D0 (en) | Benzotrizepinone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |